Device Trial Radar · NCT04409561
Reference Range for abioSCOPE® Device With the PSP Assay in a Generally Healthy Adult Population
Last checked: Nov 19, 2026Latest source record: Mar 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Actual
Start
Nov 15, 2021
Primary completion
Nov 15, 2021
Study completion Jan 15, 2022
Sponsor
- Lead sponsor
- Abionic SANot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Boston Biomedical Associates; Ocean State Clinical Coordinating Center
- First posted
- Jun 1, 2020
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
This is a single center, prospective, biomarker-result-blinded observational study evaluating immunoassay measurements of pancreatic stone protein (PSP) performed on Abionic's abioSCOPE device with the PSP assay on generally healthy adults representative of the US population.
Conditions
- Sepsis
- Septic Shock
- Healthy
Interventions
Blood collectionDevice
9 mL K3-EDTA anticoagulated venous whole blood and 9 mL lithium heparin anticoagulated venous whole blood will be collected, processed in plasma and stored until the shipment to the sponsor for PSP measurement on the abioSCOPE device with IVD CAPSULE PSP kits
Primary outcomes
What the sponsor says the trial is designed to measure.
- Determination of reference range interval of PSPTime frame: Day 1
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mercy Health St. Vincent
Toledo, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.